To assess the capacity of enrolled individuals to mount a Mtb-specific immune response, we analyzed CD4+ T cell responses to a peptide pool of Mtb-derived T cell epitopes (MTB300) in a subset of participants previously evaluated for the TB-SCORE (TB = 11; TBI = 11; TBI-IMID = 11). This evidence concerns the gene CD4 and tuberculosis.